(Q46391214)

21 December 2017

title

The safety and effectiveness of newer antiepileptics: a comparative postmarketing cohort study (English)

1 reference

21 December 2017

author name string

Nayan V Acharya

1

1 reference

21 December 2017

Ruth M Pickering

2

1 reference

21 December 2017

Lynda W Wilton

3

1 reference

21 December 2017

Saad A W Shakir

4

1 reference

21 December 2017

publication date

1 April 2005

1 reference

21 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

21 December 2017

volume

45

1 reference

21 December 2017

issue

4

1 reference

21 December 2017

page(s)

385-393

1 reference

21 December 2017

Remission of epilepsy: results from the National General Practice Study of Epilepsy.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Antiepileptic drugs. A review of clinically significant drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

New antiepileptic drugs: a systematic review of their efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Prescription-event monitoring--recent progress and future horizons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Safety of long-term lamotrigine in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

New antiepileptic drugs: comparison of key clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Pilot study of prescription-event monitoring in Japan comparing troglitazone with alternative oral hypoglycemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Safety review of adult clinical trial experience with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Overview of the safety of newer antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Visual field defects with vigabatrin: epidemiology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Visual field defect associated with vigabatrin: observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

Human Safety of Lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004273678

21 January 2018

Identifiers

DOI

10.1177/0091270004273678

1 reference

21 December 2017

1 reference

21 December 2017